Drugs /
mannitol
Overview
Clinical Trials
Mannitol has been investigated in 2 clinical trials, of which 2 are open and 0 are closed. Of the trials investigating mannitol, 1 is phase 1/phase 2 (1 open) and 1 is phase 2 (1 open).
EGFR Overexpression is the most frequent biomarker inclusion criterion for mannitol clinical trials.
Glioblastoma, anaplastic astrocytoma, and anaplastic oligoastrocytoma are the most common diseases being investigated in mannitol clinical trials [2].
Drug Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.